Burke Delange, DO
Vascular Surgery · Show Low, AZNPI 1801866876
Payments from drug & device makers
What this record shows
15 manufacturers reported payments, led by Penumbra, Inc. at 54.8% of the total. Reporting peaked in 2022 at $2,115 and has fallen 91.1% since, to $189 in 2025. That places this record below the midpoint for vascular surgery clinicians in AZ, where the typical reported total is $6,983.
Across 77 payments — averaging $90.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$4K
- Abbott$2K
- W. L. Gore & Associates, Inc.$596
- Boston Scientific$222
- Stryker$102
- Medtronic$76
- plus $195 from 9 others
What the payments were for
- Travel & lodging$3,73053%
- Food & beverage$3,25347%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 12 | $3,826 |
| Abbott | 13 | $1,966 |
| W. L. Gore & Associates, Inc. | 22 | $596 |
| Boston Scientific | 14 | $222 |
| Stryker | 1 | $102 |
| Medtronic | 4 | $76 |
| KCI USA, Inc. | 2 | $39 |
| Cardiovascular Systems Inc. | 1 | $26 |
| Bolton Medical Inc | 1 | $23 |
| Surmodics, Inc. | 2 | $21 |
| Inari Medical, Inc. | 1 | $20 |
| TELA Bio, Inc. | 1 | $18 |
| Silk Road Medical, Inc. | 1 | $16 |
| Davol Inc. | 1 | $16 |
| Smith+Nephew | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$2,225
- Omnilink Elite vascular stent system$1,573
- RUBY Coil$1,455
- SPY-PHI SYSTEM$102
How this compares
$6,983 in reported general payments places this provider in the 50th percentile of 105 vascular surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 36 | $29,351 |
| ClopidogrelClopidogrel Bisulfate | 97 | $1,254 |
| Pantoprazole Sodium | 182 | $1,095 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 68 | $1,091 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 160 | $1,036 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 61 | $1,021 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 26 | $732 |
| Cilostazol | 16 | $384 |
| Sucralfate | 14 | $316 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $191 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Show Low
- Venkatesh RamaiahScottsdale$452K
- Jeromy BrinkPhoenix$392K
- Luis LeonPhoenix$185K
- Hammad AmerMesa$169K
- Baljeet UppalSun City$166K
- Scott BermanTuscon$150K
- Martin ZomayaPhoenix$139K
- Joshua BaldermanTucson$135K
- John PacanowskiTucson$85K
- Joseph VijungcoChandler$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.